122 related articles for article (PubMed ID: 9122687)
21. Mutation of the PTEN (MMAC1) tumor suppressor gene in a subset of glioblastomas but not in meningiomas with loss of chromosome arm 10q.
Boström J; Cobbers JM; Wolter M; Tabatabai G; Weber RG; Lichter P; Collins VP; Reifenberger G
Cancer Res; 1998 Jan; 58(1):29-33. PubMed ID: 9426052
[TBL] [Abstract][Full Text] [Related]
22. Structural and functional evidence for the presence of tumor suppressor genes on the short arm of chromosome 10 in human gliomas.
Kon H; Sonoda Y; Kumabe T; Yoshimoto T; Sekiya T; Murakami Y
Oncogene; 1998 Jan; 16(2):257-63. PubMed ID: 9464544
[TBL] [Abstract][Full Text] [Related]
23. [Involvement of protein tyrosine phosphatases in cancer development].
Hinoda Y; Idogawa M; Imai K
Tanpakushitsu Kakusan Koso; 1998 Jun; 43(8 Suppl):1186-92. PubMed ID: 9655978
[No Abstract] [Full Text] [Related]
24. The gene for leukocyte antigen-related tyrosine phosphatase (LAR) is localized to human chromosome 1p32, a region frequently deleted in tumors of neuroectodermal origin.
Jirik FR; Harder KW; Melhado IG; Anderson LL; Duncan AM
Cytogenet Cell Genet; 1992; 61(4):266-8. PubMed ID: 1486801
[TBL] [Abstract][Full Text] [Related]
25. Detection of CDKN2 deletions in tumor cell lines and primary glioma by interphase fluorescence in situ hybridization.
Dreyling MH; Bohlander SK; Adeyanju MO; Olopade OI
Cancer Res; 1995 Mar; 55(5):984-8. PubMed ID: 7867008
[TBL] [Abstract][Full Text] [Related]
26. Chromosomal localization of four human VH1-like protein-tyrosine phosphatases.
Martell KJ; Kwak S; Hakes DJ; Dixon JE; Trent JM
Genomics; 1994 Jul; 22(2):462-4. PubMed ID: 7806236
[TBL] [Abstract][Full Text] [Related]
27. The putative glioma tumor suppressor gene on chromosome 19q maps between APOC2 and HRC.
Rubio MP; Correa KM; Ueki K; Mohrenweiser HW; Gusella JF; von Deimling A; Louis DN
Cancer Res; 1994 Sep; 54(17):4760-3. PubMed ID: 8062276
[TBL] [Abstract][Full Text] [Related]
28. Chromosome 10 deletion mapping in human gliomas: a common deletion region in 10q25.
Rasheed BK; McLendon RE; Friedman HS; Friedman AH; Fuchs HE; Bigner DD; Bigner SH
Oncogene; 1995 Jun; 10(11):2243-6. PubMed ID: 7784070
[TBL] [Abstract][Full Text] [Related]
29. Deletion of PTEN in a patient with Bannayan-Riley-Ruvalcaba syndrome suggests allelism with Cowden disease.
Arch EM; Goodman BK; Van Wesep RA; Liaw D; Clarke K; Parsons R; McKusick VA; Geraghty MT
Am J Med Genet; 1997 Sep; 71(4):489-93. PubMed ID: 9286463
[TBL] [Abstract][Full Text] [Related]
30. Evidence for a novel tumor suppressor gene on chromosome 15 associated with progression to a metastatic stage in breast cancer.
Wick W; Petersen I; Schmutzler RK; Wolfarth B; Lenartz D; Bierhoff E; Hümmerich J; Müller DJ; Stangl AP; Schramm J; Wiestler OD; von Deimling A
Oncogene; 1996 Mar; 12(5):973-8. PubMed ID: 8649814
[TBL] [Abstract][Full Text] [Related]
31. FGFR2 and WDR11 are neighboring oncogene and tumor suppressor gene on human chromosome 10q26.
Katoh M; Katoh M
Int J Oncol; 2003 May; 22(5):1155-9. PubMed ID: 12684685
[TBL] [Abstract][Full Text] [Related]
32. PTEN/MMAC1 mutations in primary glioblastomas and short-term cultures of malignant gliomas.
Chiariello E; Roz L; Albarosa R; Magnani I; Finocchiaro G
Oncogene; 1998 Jan; 16(4):541-5. PubMed ID: 9484844
[TBL] [Abstract][Full Text] [Related]
33. Distinct regions of allelic imbalance on chromosome 10q22-q26 in squamous cell carcinomas of the lung.
Petersen S; Rudolf J; Bockmühl U; Gellert K; Wolf G; Dietel M; Petersen I
Oncogene; 1998 Jul; 17(4):449-54. PubMed ID: 9696038
[TBL] [Abstract][Full Text] [Related]
34. Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation.
Marsh DJ; Coulon V; Lunetta KL; Rocca-Serra P; Dahia PL; Zheng Z; Liaw D; Caron S; Duboué B; Lin AY; Richardson AL; Bonnetblanc JM; Bressieux JM; Cabarrot-Moreau A; Chompret A; Demange L; Eeles RA; Yahanda AM; Fearon ER; Fricker JP; Gorlin RJ; Hodgson SV; Huson S; Lacombe D; Eng C
Hum Mol Genet; 1998 Mar; 7(3):507-15. PubMed ID: 9467011
[TBL] [Abstract][Full Text] [Related]
35. P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase.
Myers MP; Stolarov JP; Eng C; Li J; Wang SI; Wigler MH; Parsons R; Tonks NK
Proc Natl Acad Sci U S A; 1997 Aug; 94(17):9052-7. PubMed ID: 9256433
[TBL] [Abstract][Full Text] [Related]
36. Transformation of human glioma cell lines with the p16 gene inhibits cell proliferation.
Hama S; Sadatomo T; Yoshioka H; Kurisu K; Tahara E; Naruse I; Heike Y; Saijo N
Anticancer Res; 1997; 17(3C):1933-8. PubMed ID: 9216647
[TBL] [Abstract][Full Text] [Related]
37. Mutation analysis of the putative tumor suppressor PTEN/MMAC1 in human ovarian cancer.
Yokomizo A; Tindall DJ; Hartmann L; Jenkins RB; Smith DI; Liu W
Int J Oncol; 1998 Jul; 13(1):101-5. PubMed ID: 9625810
[TBL] [Abstract][Full Text] [Related]
38. Pten signaling in gliomas.
Knobbe CB; Merlo A; Reifenberger G
Neuro Oncol; 2002 Jul; 4(3):196-211. PubMed ID: 12084351
[TBL] [Abstract][Full Text] [Related]
39. A study of the PTEN/MMAC1 gene in 136 breast cancer families.
Chen J; Lindblom P; Lindblom A
Hum Genet; 1998 Jan; 102(1):124-5. PubMed ID: 9490290
[No Abstract] [Full Text] [Related]
40. Loss of heterozygosity on chromosome 10q23 and mutation of the phosphatase and tensin homolog deleted from chromosome 10 tumor suppressor gene in Korean hepatocellular carcinoma patients.
Bae JJ; Rho JW; Lee TJ; Yun SS; Kim HJ; Choi JH; Jeong D; Jang BC; Lee TY
Oncol Rep; 2007 Oct; 18(4):1007-13. PubMed ID: 17786367
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
